RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Filing today Who cares what the board "feels"
They tried to deliver a cancer program with some value and mostly failed, it happens often. That killed the hope. Maybe they can pull something out of the ashes because there is a hint of drug activity, that's about it.
canadapiet wrote: "It is worth remembering that Marathon likely cares less about shareholders interests than the board of THTX does"
Really????
You are becoming "the clown" of the message board man!
When did the board of TH take care of the shareholders??????
Like i (and many others) pointed out a long time before: THEY DON'T CARE ABOUT THE SHAREHOLDERS!!!!
Man, look at all they did the last years............., there are people put in jail for less!!
Amen! (may God bless you....., but i think he is in another "universe")
SPCEO1 - (11/7/2023 1:53:51 PM)
RE:RE:RE:RE:RE:RE:RE:RE:New Filing today
The chances of an adjusted EBITDA breech seem low, but if it did happen I suspect that would open the door for MArathon to come in and grab the assets. I am not sure what recourse THTX might have in such a situation. Previously, the best way for Marathon to get their cash back was to renegotiate the loan after a breech, earn some extra fees and then let THTX run its business to generate teh needed cah. With $60 million in loans outstnading and around $48 million in cash on the balance sheet right now, the way Marathon may look at another breech, should it even happen, may be diffferent. For example, if there are good results on cancer recently reported, then taking the company's assets versus renegotiating might produce a bonanza for Marathon.
It is worth remembering that Marathon likely cares less about shareholders interests than the board of THTX does. So, I am wondering what PWIB, who has some experience in this area, might think about this admittedly remote risk.